EUVIMEDEUVIMED entdecken
Crossref

Defensins (HAD-1/HBD-1) as novel immune biomarkers in chronic hepatitis C: Association with inflammatory and antiviral cytokines and ROC-based diagnostic accuracy

Ahmed T Enad, Al-Zahraa J Jassim, Thuraya K Alwandawi, Ruqaya K Abbas

The Egyptian journal of Immunology · 01.07.2026 · 33 (3) · 72-81

DOI: 10.55133/eji.330308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian journal of Immunology, online erschienen am 01.07.2026. Verfasst von Ahmed T Enad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Cytokines, beta-Defensins, alpha-Defensins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic hepatitis C virus (HCV) infection is associated with prolonged immune activation and systemic inflammation, which may be reflected in circulating immune mediators. Defensins and cytokines have emerged as potential biomarkers for monitoring immune dysregulation in chronic viral hepatitis. This study aimed to monitoring serum levels of human α-defensin-1 (HAD-1) and human β-defensin-1 (HBD-1) with selected cytokines (IL-6, IL-28, TNF-α, and IFN-) in Iraqi patients with chronic HCV and to evaluate their diagnostic performance by the receiver operating characteristic (ROC) analysis. This cross-sectional case–control study was conducted in Iraq during February–November 2025. It included 100 laboratory-confirmed chronic HCV patients and 50 normal controls. Serum HAD-1, HBD-1, IL-6, IL-28, TNF-α, and IFN- were measured by ELISA. Hematological indices and liver function markers were also analyzed. HCV patients showed significantly increased HAD-1 and HBD-1 levels compared with controls (p< 0.01). Cytokine profiling revealed markedly elevated IL-6, IL-28, TNF-α, and IFN- levels in patients, indicating strong activation of inflammatory and antiviral immune pathways (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicCytokinesbeta-Defensinsalpha-DefensinsHumansBiomarkersFemaleMaleAdultCase-Control StudiesCross-Sectional StudiesROC CurveMiddle AgedHepacivirus

Substanzen

BiomarkersCytokinesbeta-Defensinsalpha-DefensinsDEFB1 protein, human

Autor:innen und Institutionen

  • Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad.
  • Al-Iraqia University, Baghdad, Iraq.

Zitieren

APA

Enad, A. T., Jassim, A. J., Alwandawi, T. K., & Abbas, R. K. (2026). Defensins (HAD-1/HBD-1) as novel immune biomarkers in chronic hepatitis C: Association with inflammatory and antiviral cytokines and ROC-based diagnostic accuracy. The Egyptian journal of Immunology, 33(3), 72-81. https://doi.org/10.55133/eji.330308

Vancouver

Enad AT, Jassim AJ, Alwandawi TK, Abbas RK. Defensins (HAD-1/HBD-1) as novel immune biomarkers in chronic hepatitis C: Association with inflammatory and antiviral cytokines and ROC-based diagnostic accuracy. The Egyptian journal of Immunology. 2026;33(3):72-81. doi:10.55133/eji.330308

BibTeX
@article{Enad2026,
  author = {Enad, Ahmed T and Jassim, Al-Zahraa J and Alwandawi, Thuraya K and Abbas, Ruqaya K},
  title = {Defensins (HAD-1/HBD-1) as novel immune biomarkers in chronic hepatitis C: Association with inflammatory and antiviral cytokines and ROC-based diagnostic accuracy},
  journal = {The Egyptian journal of Immunology},
  year = {2026},
  volume = {33},
  number = {3},
  pages = {72--81},
  doi = {10.55133/eji.330308}
}
Kostenlos starten →